您的位置: 首页 > 农业专利 > 详情页

Imunska modulacija preko lektina tipa C
专利权人:
CANCER RESEARCH TECHNOLOGY LIMITED
发明人:
SANCHO-MADRID DAVID,SCHULZ OLIVER,ROGERS NEIL CHARLES,REIS E SOUSA CAETANO,PENNINGTON DANIEL,JOFFRE OLIVIER PIERRE,Sancho-Madrid David,Schulz Oliver,Rogers Neil Charles,Reis E Sousa Caetano,Pennington Daniel,JOFFRE OLIVIER
申请号:
SI200831558
公开号:
SI2185586T1
申请日:
2008.07.21
申请国别(地区):
SI
年份:
2016
代理人:
摘要:
The invention relates to the regulation of the immune system, and in particular to the finding that the CLEC9a molecule is a marker for dendritic cells which are capable of cross-presenting extracellular antigens via the MHC class I pathway. This makes them particularly suitable for generation of cytotoxic T lymphocyte responses. Materials and methods are provided both for the induction of immune responses against target antigens, and for the inhibition or suppression of undesirable immune responses in which these cells are involved.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充